ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

ClinicalTrials.gov ID: NCT01421511

Public ClinicalTrials.gov record NCT01421511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of IV to Oral 6-Day TR-701 Free Acid and IV to Oral 10-Day Linezolid for the Treatment of ABSSSI

Study identification

NCT ID
NCT01421511
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry
Enrollment
666 participants

Conditions and interventions

Interventions

  • Linezolid Drug
  • TR-701 FA Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2011
Primary completion
Jan 9, 2013
Completion
Jan 9, 2013
Last update posted
Aug 28, 2018

2011 – 2013

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
34
Facility City State ZIP Site status
Trius investigator site 159 Dothan Alabama 36305
Trius investigator site 103 Chula Vista California 91911
Trius investigator site 143 Escondido California 92025
Trius investigator site 105 La Mesa California 91942
Trius investigator site 106 Long Beach California 90813
Trius investigator site 157 Long Beach California 90813
Trius investigator site 142 National City California 91950
Trius investigator site 170 San Diego California 92123
Trius investigator site 167 Santa Ana California 92701
Trius investigator site 168 Stockton California 95204
Trius investigator site 141 Sylmar California 91342
Trius investigator site 139 Denver Colorado 80218
Trius investigator site 137 Newark Delaware 19718
Trius investigator site 166 Edgewater Florida 32132
Trius investigator site 101 Columbus Georgia 31904
Trius investigator site 138 Carmel Indiana 46032
Trius investigator site 144 Owensboro Kentucky 42303
Trius investigator site 150 Baton Rouge Louisiana 70809
Trius investigator site 165 Eunice Louisiana 70535
Trius investigator site 154 Boston Massachusetts 02115
Trius investigator site 146 Springfield Massachusetts 01199
Trius investigator site 136 West Roxbury Massachusetts 02132
Trius investigator site 163 Royal Oak Michigan 48073
Trius investigator site 153 Minneapolis Minnesota 55415
Trius investigator site 149 Picayune Mississippi 39466
Trius investigator site 164 Creve Coeur Missouri 63141
Trius investigator site 160 Las Vegas Nevada 89169
Trius investigator site 147 Teaneck New Jersey 07666
Trius investigator site 140 Columbus Ohio 43215
Trius investigator site 162 Lima Ohio 45801
Trius investigator site 161 Rapid City South Dakota 57702
Trius investigator site 155 Franklin Tennessee 37064
Trius investigator site 145 Memphis Tennessee 38104
Trius investigator site 169 Smyrna Tennessee 37167
Trius investigator site 148 Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01421511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 28, 2018 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01421511 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →